|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Minireview |
Department of Obstetrics and Gynecology,2 University of Leipzig, 04103 Leipzig, Germany
Department of Cell Biology,3 Histology and Embryology, Medical University of Graz, 8010 Graz, Austria
Department of Molecular Biological-Biochemical Processing Technology,4 Center of Biotechnology and Biomedicine, University of Leipzig, 04103 Leipzig, Germany
Department of Pharmacology,5 Erasmus Medical Center, 3000 Rotterdam, The Netherlands
Department of Cardiology,6 Charité, Campus Benjamin Franklin, 12200 Berlin, Germany
Despite recent research progress, the biology of preeclampsia is still poorly understood and neither effective prediction nor causal therapy have yet emerged. Nevertheless, recent studies have documented new and exciting pathophysiological mechanisms for the origin and development of preeclampsia. These studies provide a more differentiated view on alterations of particular peptide systems with strong impact on angiogenesis and cardiovascular regulation in this pregnancy disorder. With the identification of the antiangiogenic factor soluble fms-like tyrosine kinase 1 and the agonistic autoantibody to the angiotensin II type 1 receptor, two factors have been described with a clear linkage to the development of the disease. This review focuses on the most recent and relevant insights into the biology of preeclampsia and develops hypotheses regarding possible links between the reported aspects of preeclampsia.
placenta, pregnancy, signal transduction, trophoblast
This article has been cited by other articles:
![]() |
F. Collino, B. Bussolati, E. Gerbaudo, L. Marozio, S. Pelissetto, C. Benedetto, and G. Camussi Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1185 - F1194. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Thomas, J. I. Andrews, and K. Z. Liu Intronic polyadenylation signal sequences and alternate splicing generate human soluble Flt1 variants and regulate the abundance of soluble Flt1 in the placenta FASEB J, December 1, 2007; 21(14): 3885 - 3895. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-L. Dong, D. M. Reddy, K. E. Green, M. S. Chauhan, H.-Q. Wang, M. Nagamani, G. D.V. Hankins, and C. Yallampalli Calcitonin Gene-Related Peptide (CALCA) Is a Proangiogenic Growth Factor in the Human Placental Development Biol Reprod, May 1, 2007; 76(5): 892 - 899. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Zhou, S. Ahmad, T. Mi, L. Xia, S. Abbasi, P. W. Hewett, C. Sun, A. Ahmed, R. E. Kellems, and Y. Xia Angiotensin II Induces Soluble fms-Like Tyrosine Kinase-1 Release via Calcineurin Signaling Pathway in Pregnancy Circ. Res., January 5, 2007; 100(1): 88 - 95. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |